AgonOx Signs On MedImmune as Global Partner for Cancer Therapeutics Platform
- 9:46 AM — Oct 31 —
- Source: Genetic Engineering News
AgonOx entered into an exclusive, global partnership with MedImmune to develop agonists using its OX40 platform. Read More
Advertisement
Ox
On Sale
Hot Music News
Adam Levine Romancing New Model
Catwalk Queen Caught Kissing Rocker
Jessica's Shocking Sex Confession
Jessica Simpson's Bedroom Tell-All
Life After Living in the Kardashian Shadow
Singer Fights to Shake the Kardashian Curse
Infertility Struggles Revealed
Joe Nichols Opens Up About Baby Drama